Lv5
1070 积分 2025-07-02 加入
Population Pharmacokinetic Modeling of Canagliflozin in Advanced Chronic Kidney Disease
1个月前
已完结
Pharmacokinetics, Pharmacodynamics, and Safety of Olorigliflozin in Individuals with Type 2 Diabetes Mellitus with or without Renal Impairment: A Single-Center, Single-Dose, Open-Label Trial
1个月前
已完结
Gut Microbiota as the Potential Mechanism to Mediate Drug Metabolism UnderHigh-altitude Hypoxia
2个月前
已完结
Clinical Pharmacokinetics and Pharmacodynamics of Dapagliflozin, a Selective Inhibitor of Sodium-Glucose Co-transporter Type 2
5个月前
已完结
Downregulation of Hepatic Cytochrome P450 in Chronic Renal Failure
5个月前
已完结
Age-dependent pharmacokinetics of nifedipine in spontaneous hypertensive rats are associated with changes in gut microbiota and hepatic CYP3A1 expression
6个月前
已关闭
Pharmacokinetics of rosuvastatin in patients with end-stage kidney disease undergoing peritoneal dialysis
6个月前
已完结
Acute Effects of High-Dose Furosemide on Residual Renal Function in CAPD Patients
6个月前
已完结
Antibiotic-induced neurological adverse drug reactions
6个月前
已关闭
Acute Effects of High-Dose Furosemide on Residual Renal Function in CAPD Patients
7个月前
已完结
皖公网安备34019202002308
